BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17180739)

  • 1. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma.
    Yilmazer D; Han U; Onal B
    Int Urol Nephrol; 2007; 39(3):691-8. PubMed ID: 17180739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels.
    Ruiz-Saurí A; García-Bustos V; Granero E; Cuesta S; Sales MA; Marcos V; Llombart-Bosch A
    Pathol Oncol Res; 2018 Jul; 24(3):515-524. PubMed ID: 28669081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma].
    Zhang YH; Yang Q; Cui W; Liu YX; Liu SX; Yao X
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):117-22. PubMed ID: 20403242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
    Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
    Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model.
    Qu HM; Liu SJ; Zhang CY
    Int J Biol Macromol; 2014 May; 66():52-6. PubMed ID: 24556120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
    Jacobsen J; Grankvist K; Rasmuson T; Bergh A; Landberg G; Ljungberg B
    BJU Int; 2004 Feb; 93(3):297-302. PubMed ID: 14764126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour.
    Ozluk Y; Kilicaslan I; Gulluoglu MG; Ayan I; Uysal V
    Pathology; 2006 Oct; 38(5):408-14. PubMed ID: 17008278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the vascular endothelial growth factor (VEGF) expression and microvascular density (MVD) in primary colorectal cancer specimens.
    Anannamcharoen S; Nimmanon T
    J Med Assoc Thai; 2012 Aug; 95(8):1041-7. PubMed ID: 23061308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFR3 and CD31 as prognostic factors in renal cell cancer.
    Virman J; Bono P; Luukkaala T; Sunela K; Kujala P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2015 Feb; 35(2):921-7. PubMed ID: 25667475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
    El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
    Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular network in renal carcinomas. Quantitative and tissue microarray immunohistochemical study.
    Okoń K; Kawa R
    Pol J Pathol; 2008; 59(2):107-15. PubMed ID: 18669177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor in renal cell carcinomas.
    Paradis V; Lagha NB; Zeimoura L; Blanchet P; Eschwege P; Ba N; Benoît G; Jardin A; Bedossa P
    Virchows Arch; 2000 Apr; 436(4):351-6. PubMed ID: 10834538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.